{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:11:59Z","timestamp":1778944319377,"version":"3.51.4"},"reference-count":91,"publisher":"Pharmaceutical Society of Japan","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1248\/bpb.b20-00932","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T22:14:59Z","timestamp":1622499299000},"page":"789-797","source":"Crossref","is-referenced-by-count":17,"title":["Acute Ramelteon Treatment Maintains the Cardiac Rhythms of Rats during Non-REM Sleep"],"prefix":"10.1248","volume":"44","author":[{"given":"Airi","family":"Yoshimoto","sequence":"first","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Yamashiro","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ikegaya","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Tokyo"},{"name":"Institute for AI and Beyond, The University of Tokyo"},{"name":"Center for Information and Neural Networks, National Institute of Information and Communications Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Van Cauter E, Spiegel K, Tasali E, Leproult R. Metabolic consequences of sleep and sleep loss. <i>Sleep Med.<\/i>, <b>9<\/b> (Suppl. 1), S23\u2013S28 (2008).","DOI":"10.1016\/S1389-9457(08)70013-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Aserinsky E, Kleitman N. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. <i>Science<\/i>, <b>118<\/b>, 273\u2013274 (1953).","DOI":"10.1126\/science.118.3062.273"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jouvet M. Paradoxical sleep\u2014a study of its nature and mechanisms. <i>Prog. Brain Res.<\/i>, <b>18<\/b>, 20\u201362 (1965).","DOI":"10.1016\/S0079-6123(08)63582-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. <i>N. Engl. J. Med.<\/i>, <b>328<\/b>, 303\u2013307 (1993).","DOI":"10.1056\/NEJM199302043280502"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Coote JH. Respiratory and circulatory control during sleep. <i>J. Exp. Biol.<\/i>, <b>100<\/b>, 223\u2013244 (1982).","DOI":"10.1242\/jeb.100.1.223"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Szymusiak R. Body temperature and sleep. <i>Handb. Clin. Neurol.<\/i>, <b>156<\/b>, 341\u2013351 (2018).","DOI":"10.1016\/B978-0-444-63912-7.00020-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) de Andr\u00e9s I, Garz\u00f3n M, Reinoso-Su\u00e1rez F. Functional anatomy of non-REM sleep. <i>Front. Neurol.<\/i>, <b>2<\/b>, 70 (2011).","DOI":"10.3389\/fneur.2011.00070"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. <i>Sleep<\/i>, <b>30<\/b>, 213\u2013218 (2007).","DOI":"10.1093\/sleep\/30.2.213"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Visconti L, Santoro D, Cernaro V, Buemi M, Lacquaniti A. Kidney-lung connections in acute and chronic diseases: current perspectives. <i>J. Nephrol.<\/i>, <b>29<\/b>, 341\u2013348 (2016).","DOI":"10.1007\/s40620-016-0276-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Pigarev IN, Pigareva ML. Association of sleep impairments and gastrointestinal disorders in the context of the visceral theory of sleep. <i>J. Integr. Neurosci.<\/i>, <b>16<\/b>, 143\u2013156 (2017).","DOI":"10.3233\/JIN-170005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Covassin N, Singh P. Sleep duration and cardiovascular disease risk: epidemiologic and experimental evidence. <i>Sleep Med. Clin.<\/i>, <b>11<\/b>, 81\u201389 (2016).","DOI":"10.1016\/j.jsmc.2015.10.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kasai T. Sleep apnea and heart failure. <i>J. Cardiol.<\/i>, <b>60<\/b>, 78\u201385 (2012).","DOI":"10.1016\/j.jjcc.2012.05.013"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. <i>Br. J. Pharmacol.<\/i>, <b>175<\/b>, 3190\u20133199 (2018).","DOI":"10.1111\/bph.14116"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. <i>Arch. Endocrinol. Metab.<\/i>, <b>62<\/b>, 472\u2013479 (2018).","DOI":"10.20945\/2359-3997000000066"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) P\u00e9vet P. Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus. <i>Expert Opin. Ther. Targets<\/i>, <b>20<\/b>, 1209\u20131218 (2016).","DOI":"10.1080\/14728222.2016.1179284"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML. MT<sub>1<\/sub> and MT<sub>2<\/sub> melatonin receptors: a therapeutic perspective. <i>Annu. Rev. Pharmacol. Toxicol.<\/i>, <b>56<\/b>, 361\u2013383 (2016).","DOI":"10.1146\/annurev-pharmtox-010814-124742"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hastings MH, Maywood ES, Brancaccio M. Generation of circadian rhythms in the suprachiasmatic nucleus. <i>Nat. Rev. Neurosci.<\/i>, <b>19<\/b>, 453\u2013469 (2018).","DOI":"10.1038\/s41583-018-0026-z"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Miyamoto M, Nishikawa H, Doken Y, Hirai K, Uchikawa O, Ohkawa S. The sleep-promoting action of ramelteon (TAK-375) in freely moving cats. <i>Sleep<\/i>, <b>27<\/b>, 1319\u20131325 (2004).","DOI":"10.1093\/sleep\/27.7.1319"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M. Neurochemical properties of ramelteon (TAK-375), a selective MT<sub>1<\/sub>\/MT<sub>2<\/sub> receptor agonist. <i>Neuropharmacology<\/i>, <b>48<\/b>, 301\u2013310 (2005).","DOI":"10.1016\/j.neuropharm.2004.09.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yukuhiro N, Kimura H, Nishikawa H, Ohkawa S, Yoshikubo S, Miyamoto M. Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys. <i>Brain Res.<\/i>, <b>1027<\/b>, 59\u201366 (2004).","DOI":"10.1016\/j.brainres.2004.08.035"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hirai K, Kita M, Ohta H, Nishikawa H, Fujiwara Y, Ohkawa S, Miyamoto M. Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light\u2013dark cycle in rats. <i>J. Biol. Rhythms<\/i>, <b>20<\/b>, 27\u201337 (2005).","DOI":"10.1177\/0748730404269890"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Miyamoto M. Effect of ramelteon (TAK-375), a selective MT<sub>1<\/sub>\/MT<sub>2<\/sub> receptor agonist, on motor performance in mice. <i>Neurosci. Lett.<\/i>, <b>402<\/b>, 201\u2013204 (2006).","DOI":"10.1016\/j.neulet.2006.02.049"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Neubauer DN. A review of ramelteon in the treatment of sleep disorders. <i>Neuropsychiatr. Dis. Treat.<\/i>, <b>4<\/b>, 69\u201379 (2008).","DOI":"10.2147\/NDT.S483"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Miyamoto M. Pharmacology of ramelteon, a selective MT<sub>1<\/sub>\/MT<sub>2<\/sub> receptor agonist: a novel therapeutic drug for sleep disorders. <i>CNS Neurosci. Ther.<\/i>, <b>15<\/b>, 32\u201351 (2009).","DOI":"10.1111\/j.1755-5949.2008.00066.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Torii H, Ando M, Tomita H, Kobaru T, Tanaka M, Fujimoto K, Shimizu R, Ikesue H, Okusada S, Hashida T, Kume N. Association of hypnotic drug use with fall incidents in hospitalized elderly patients: a case-crossover study. <i>Biol. Pharm. Bull.<\/i>, <b>43<\/b>, 925\u2013931 (2020).","DOI":"10.1248\/bpb.b19-00684"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Uchinaka A, Kawashima Y, Sano Y, Ito S, Sano Y, Nagasawa K, Matsuura N, Yoneda M, Yamada Y, Murohara T, Nagata K. Effects of ramelteon on cardiac injury and adipose tissue pathology in rats with metabolic syndrome. <i>Ann. N. Y. Acad. Sci.<\/i>, <b>1421<\/b>, 73\u201387 (2018).","DOI":"10.1111\/nyas.13578"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Stroethoff M, Christoph I, Behmenburg F, Raupach A, Bunte S, Senpolat S, Heinen A, Hollmann MW, Mathes A, Huhn R. Melatonin receptor agonist ramelteon reduces ischemia\u2013reperfusion injury through activation of mitochondrial potassium channels. <i>J. Cardiovasc. Pharmacol.<\/i>, <b>72<\/b>, 106\u2013111 (2018).","DOI":"10.1097\/FJC.0000000000000600"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Stroethoff M, Behmenburg F, Spittler K, Raupach A, Heinen A, Hollmann MW, Huhn R, Mathes A. Activation of melatonin receptors by ramelteon induces cardioprotection by postconditioning in the rat heart. <i>Anesth. Analg.<\/i>, <b>126<\/b>, 2112\u20132115 (2018).","DOI":"10.1213\/ANE.0000000000002625"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Stroethoff M, Goetze L, Torregroza C, Bunte S, Raupach A, Heinen A, Mathes A, Hollmann MW, Huhn R. The melatonin receptor agonist ramelteon induces cardioprotection that requires MT<sub>2<\/sub> receptor activation and release of reactive oxygen species. <i>Cardiovasc. Drugs Ther.<\/i>, <b>34<\/b>, 303\u2013310 (2020).","DOI":"10.1007\/s10557-020-06972-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Baltatu OC, Senar S, Campos LA, Cipolla-Neto J. Cardioprotective melatonin: translating from proof-of-concept studies to therapeutic use. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, 4342 (2019).","DOI":"10.3390\/ijms20184342"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sasaki T, Nishimura Y, Ikegaya Y. Simultaneous recordings of central and peripheral bioelectrical signals in a freely moving rodent. <i>Biol. Pharm. Bull.<\/i>, <b>40<\/b>, 711\u2013715 (2017).","DOI":"10.1248\/bpb.b17-00070"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Shikano Y, Sasaki T, Ikegaya Y. Simultaneous recordings of cortical local field potentials, electrocardiogram, electromyogram, and breathing rhythm from a freely moving rat. <i>J. Vis. Exp.<\/i>, <b>134<\/b>, e56980 (2018).","DOI":"10.3791\/56980"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Okada S, Igata H, Sakaguchi T, Sasaki T, Ikegaya Y. A new device for the simultaneous recording of cerebral, cardiac, and muscular electrical activity in freely moving rodents. <i>J. Pharmacol. Sci.<\/i>, <b>132<\/b>, 105\u2013108 (2016).","DOI":"10.1016\/j.jphs.2016.06.001"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Yoshimoto A, Yamashiro K, Suzuki T, Ikegaya Y, Matsumoto N. Ramelteon modulates gamma oscillations in the rat primary motor cortex during non-REM sleep. <i>J. Pharmacol. Sci.<\/i>, <b>145<\/b>, 97\u2013104 (2021).","DOI":"10.1016\/j.jphs.2020.11.006"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Yamashiro K, Aoki M, Matsumoto N, Ikegaya Y. Polyherbal formulation enhancing cerebral slow waves in sleeping rats. <i>Biol. Pharm. Bull.<\/i>, <b>43<\/b>, 1356\u20131360 (2020).","DOI":"10.1248\/bpb.b20-00285"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Geiger BM, Frank LE, Caldera-Siu AD, Pothos EN. Survivable stereotaxic surgery in rodents. <i>J. Vis. Exp.<\/i>, <b>20<\/b>, e880 (2008).","DOI":"10.3791\/880"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Siegle JH, L\u00f3pez AC, Patel YA, Abramov K, Ohayon S, Voigts J. Open Ephys: an open-source, plugin-based platform for multichannel electrophysiology. <i>J. Neural Eng.<\/i>, <b>14<\/b>, 045003 (2017).","DOI":"10.1088\/1741-2552\/aa5eea"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Bagur S, Lacroix MM, de Lavill\u00e9on G, Lefort JM, Geoffroy H, Benchenane K. Harnessing olfactory bulb oscillations to perform fully brain-based sleep-scoring and real-time monitoring of anaesthesia depth. <i>PLOS Biol.<\/i>, <b>16<\/b>, e2005458 (2018).","DOI":"10.1371\/journal.pbio.2005458"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Mizuseki K, Diba K, Pastalkova E, Buzs\u00e1ki G. Hippocampal CA1 pyramidal cells form functionally distinct sublayers. <i>Nat. Neurosci.<\/i>, <b>14<\/b>, 1174\u20131181 (2011).","DOI":"10.1038\/nn.2894"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. <i>Front. Public Health.<\/i>, <b>5<\/b>, 258 (2017).","DOI":"10.3389\/fpubh.2017.00258"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Miyawaki H, Billeh YN, Diba K. Low activity microstates during sleep. <i>Sleep<\/i>, <b>40<\/b>, zsx066 (2017).","DOI":"10.1093\/sleep\/zsx066"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) dos Santos Lima GZ, Lobao-Soares B, Corso G, Belchior H, Lopes SR, de Lima Prado T, Nascimento G, Fran\u00e7a AC, Fontenele-Ara\u00fajo J, Ivanov PC. Hippocampal and cortical communication around micro-arousals in slow-wave sleep. <i>Sci. Rep.<\/i>, <b>9<\/b>, 5876 (2019).","DOI":"10.1038\/s41598-019-42100-5"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Gradwohl G, Olini N, Huber R. Sleep\/wake movement velocities, trajectories and micro-arousals during maturation in rats. <i>BMC Neurosci.<\/i>, <b>18<\/b>, 24 (2017).","DOI":"10.1186\/s12868-017-0343-6"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Brooks PL, Peever J. A temporally controlled inhibitory drive coordinates twitch movements during REM sleep. <i>Curr. Biol.<\/i>, <b>26<\/b>, 1177\u20131182 (2016).","DOI":"10.1016\/j.cub.2016.03.013"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Simor P, van der Wijk G, Nobili L, Peigneux P. The microstructure of REM sleep: why phasic and tonic? <i>Sleep Med. Rev.<\/i>, <b>52<\/b>, 101305 (2020).","DOI":"10.1016\/j.smrv.2020.101305"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Kuwahara M, Yayou K, Ishii K, Hashimoto S, Tsubone H, Sugano S. Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat. <i>J. Electrocardiol.<\/i>, <b>27<\/b>, 333\u2013337 (1994).","DOI":"10.1016\/S0022-0736(05)80272-9"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Lee J, Kim D, Shin H-S. Lack of delta waves and sleep disturbances during non-rapid eye movement sleep in mice lacking \u03b11G-subunit of T-type calcium channels. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>101<\/b>, 18195\u201318199 (2004).","DOI":"10.1073\/pnas.0408089101"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Montano N, Porta A, Cogliati C, Costantino G, Tobaldini E, Casali KR, Iellamo F. Heart rate variability explored in the frequency domain: a tool to investigate the link between heart and behavior. <i>Neurosci. Biobehav. Rev.<\/i>, <b>33<\/b>, 71\u201380 (2009).","DOI":"10.1016\/j.neubiorev.2008.07.006"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Carley DW, Berecek K, Videnovic A, Radulovacki M. Sleep-disordered respiration in phenotypically normotensive, genetically hypertensive rats. <i>Am. J. Respir. Crit. Care Med.<\/i>, <b>162<\/b>, 1474\u20131479 (2000).","DOI":"10.1164\/ajrccm.162.4.9911033"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Oxenkrug GF, Summergrad P. Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats. <i>Ann. N. Y. Acad. Sci.<\/i>, <b>1199<\/b>, 114\u2013120 (2010).","DOI":"10.1111\/j.1749-6632.2009.05355.x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Kario K. Are melatonin and its receptor agonist specific antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm? <i>J. Am. Soc. Hypertens.<\/i>, <b>5<\/b>, 354\u2013358 (2011).","DOI":"10.1016\/j.jash.2011.03.006"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Paulis L, Simko F, Laudon M. Cardiovascular effects of melatonin receptor agonists. <i>Expert Opin. Investig. Drugs<\/i>, <b>21<\/b>, 1661\u20131678 (2012).","DOI":"10.1517\/13543784.2012.714771"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectral analysis. <i>Am. J. Physiol.<\/i>, <b>249<\/b>, H867\u2013H875 (1985).","DOI":"10.1152\/ajpheart.1985.249.4.H867"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Rivera AL, Esta\u00f1ol B, Sent\u00edes-Madrid H, Fossion R, Toledo-Roy JC, Mendoza-Temis J, Morales IO, Landa E, Robles-Cabrera A, Moreno R, Frank A. Heart rate and systolic blood pressure variability in the time domain in patients with recent and long-standing diabetes mellitus. <i>PLOS ONE<\/i>, <b>11<\/b>, e0148378 (2016).","DOI":"10.1371\/journal.pone.0148378"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Electrophysiology TFES. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European society of cardiology and the north American society of pacing and electrophysiology. <i>Circulation<\/i>, <b>93<\/b>, 1043\u20131065 (1996).","DOI":"10.1161\/01.CIR.93.5.1043"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Ferrari AU, Daffonchio A, Albergati F, Mancia G. Inverse relationship between heart rate and blood pressure variabilities in rats. <i>Hypertension<\/i>, <b>10<\/b>, 533\u2013537 (1987).","DOI":"10.1161\/01.HYP.10.5.533"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Sin PYW, Webber MR, Galletly DC, Ainslie PN, Brown SJ, Willie CK, Sasse A, Larsen PD, Tzeng Y-C. Interactions between heart rate variability and pulmonary gas exchange efficiency in humans. <i>Exp. Physiol.<\/i>, <b>95<\/b>, 788\u2013797 (2010).","DOI":"10.1113\/expphysiol.2010.052910"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Yasuma F, Hayano J. Respiratory sinus arrhythmia: why does the heartbeat synchronize with respiratory rhythm? <i>Chest<\/i>, <b>125<\/b>, 683\u2013690 (2004).","DOI":"10.1378\/chest.125.2.683"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Bouairi E, Neff R, Evans C, Gold A, Andresen MC, Mendelowitz D. Respiratory sinus arrhythmia in freely moving and anesthetized rats. <i>J. Appl. Physiol.<\/i>, <b>97<\/b>, 1431\u20131436 (2004).","DOI":"10.1152\/japplphysiol.00277.2004"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Gonzalez NC, Kuwahira I. Systemic Oxygen Transport with Rest, Exercise, and Hypoxia: A Comparison of Humans, Rats, and Mice. <i>Comprehensive Physiology<\/i>. John Wiley &amp; Sons, Inc., Hoboken, NJ, U.S.A., pp. 1537\u20131573 (2018).","DOI":"10.1002\/cphy.c170051"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Schmidt-Neilsen K, Larimer JL. Oxygen dissociation curves of mammalian blood in relation to body size. <i>Am. J. Physiol.<\/i>, <b>195<\/b>, 424\u2013428 (1958).","DOI":"10.1152\/ajplegacy.1958.195.2.424"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Berry RB. Sleep and Obstructive Lung Disease. <i>Fundamentals of Sleep Medicine<\/i>. Chap. 22, Elsevier, The Netherlands, pp. 409\u2013428 (2012).","DOI":"10.1016\/B978-1-4377-0326-9.00022-1"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Hashimoto M, Kuwahara M, Tsubone H, Sugano S. Diurnal variation of autonomic nervous activity in the rat: investigation by power spectral analysis of heart rate variability. <i>J. Electrocardiol.<\/i>, <b>32<\/b>, 167\u2013171 (1999).","DOI":"10.1016\/S0022-0736(99)90095-X"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Mortola JP. Breathing around the clock: an overview of the circadian pattern of respiration. <i>Eur. J. Appl. Physiol.<\/i>, <b>91<\/b>, 119\u2013129 (2004).","DOI":"10.1007\/s00421-003-0978-0"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Antzelevitch C, Burashnikov A. Overview of basic mechanisms of cardiac arrhythmia. <i>Card. Electrophysiol. Clin.<\/i>, <b>3<\/b>, 23\u201345 (2011).","DOI":"10.1016\/j.ccep.2010.10.012"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Herring N, Kalla M, Paterson DJ. The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies. <i>Nat. Rev. Cardiol.<\/i>, <b>16<\/b>, 707\u2013726 (2019).","DOI":"10.1038\/s41569-019-0221-2"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Li X, Chu W, Liu J, Xue X, Lu Y, Shan H, Yang B. Antiarrhythmic properties of long-term treatment with matrine in arrhythmic rat induced by coronary ligation. <i>Biol. Pharm. Bull.<\/i>, <b>32<\/b>, 1521\u20131526 (2009).","DOI":"10.1248\/bpb.32.1521"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Choi BR, Burton F, Salama G. Cytosolic Ca<sup>2+<\/sup> triggers early afterdepolarizations and torsade de pointes in rabbit hearts with type 2 long QT syndrome. <i>J. Physiol.<\/i>, <b>543<\/b>, 615\u2013631 (2002).","DOI":"10.1113\/jphysiol.2002.024570"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Roden DM, Woosley RL, Primm RK. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. <i>Am. Heart J.<\/i>, <b>111<\/b>, 1088\u20131093 (1986).","DOI":"10.1016\/0002-8703(86)90010-4"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Sasaoka S, Matsui T, Hane Y, Abe J, Ueda N, Motooka Y, Hatahira H, Fukuda A, Naganuma M, Hasegawa S, Kinosada Y, Nakamura M. Time-to-onset analysis of drug-induced long qt syndrome based on a spontaneous reporting system for adverse drug events. <i>PLOS ONE<\/i>, <b>11<\/b>, e0164309 (2016).","DOI":"10.1371\/journal.pone.0164309"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. <i>Am. Heart J.<\/i>, <b>153<\/b>, 891\u2013899 (2007).","DOI":"10.1016\/j.ahj.2007.01.040"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Takahara A, Sugiyama A, Hashimoto K. Characterization of the halothane-anesthetized Guinea-pig heart as a model to detect the k<sup>+<\/sup> channel blocker-induced qt-interval prolongation. <i>Biol. Pharm. Bull.<\/i>, <b>29<\/b>, 827\u2013829 (2006).","DOI":"10.1248\/bpb.29.827"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Frommeyer G, Eckardt L. Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. <i>Nat. Rev. Cardiol.<\/i>, <b>13<\/b>, 36\u201347 (2016).","DOI":"10.1038\/nrcardio.2015.110"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Carnagarin R, Kiuchi MG, Ho JK, Matthews VB, Schlaich MP. Sympathetic nervous system activation and its modulation: role in atrial fibrillation. <i>Front. Neurosci.<\/i>, <b>12<\/b>, 1058 (2019).","DOI":"10.3389\/fnins.2018.01058"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Chelu MG, Wehrens XHT. Sarcoplasmic reticulum calcium leak and cardiac arrhythmias. <i>Biochem. Soc. Trans.<\/i>, <b>35<\/b>, 952\u2013956 (2007).","DOI":"10.1042\/BST0350952"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Eschenhagen T. Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure? <i>J. Clin. Invest.<\/i>, <b>120<\/b>, 4197\u20134203 (2010).","DOI":"10.1172\/JCI45251"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Eisner DA, Kashimura T, Venetucci LA, Trafford AW. From the ryanodine receptor to cardiac arrhythmias. <i>Circ. J.<\/i>, <b>73<\/b>, 1561\u20131567 (2009).","DOI":"10.1253\/circj.CJ-09-0478"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Vest JA, Wehrens XHT, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. <i>Circulation<\/i>, <b>111<\/b>, 2025\u20132032 (2005).","DOI":"10.1161\/01.CIR.0000162461.67140.4C"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Houser SR. Role of RyR2 phosphorylation in heart failure and arrhythmias: protein kinase A-mediated hyperphosphorylation of the ryanodine receptor at serine 2808 does not alter cardiac contractility or cause heart failure and arrhythmias. <i>Circ. Res.<\/i>, <b>114<\/b>, 1320\u20131327, discussion, 1327 (2014).","DOI":"10.1161\/CIRCRESAHA.114.300569"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Han D, Wang Y, Chen J, Zhang J, Yu P, Zhang R, Li S, Tao B, Wang Y, Qiu Y, Xu M, Gao E, Cao F. Activation of melatonin receptor 2 but not melatonin receptor 1 mediates melatonin-conferred cardioprotection against myocardial ischemia\/reperfusion injury. <i>J. Pineal Res.<\/i>, <b>67<\/b>, e12571 (2019).","DOI":"10.1111\/jpi.12571"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) S\u00e1nchez-Hidalgo M, Guerrero Mont\u00e1vez JM, Carrascosa-Salmoral MP, Naranjo Gutierrez MC, Lardone PJ, de la Lastra Romero CA. Carrascosa-Salmoral M del P, Naranjo Gutierrez M del C, Lardone PJ, de la Lastra Romero CA. Decreased MT<sub>1<\/sub> and MT<sub>2<\/sub> melatonin receptor expression in extrapineal tissues of the rat during physiological aging. <i>J. Pineal Res.<\/i>, <b>46<\/b>, 29\u201335 (2009).","DOI":"10.1111\/j.1600-079X.2008.00604.x"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: Distribution and functions. <i>Mol. Cell. Endocrinol.<\/i>, <b>351<\/b>, 152\u2013166 (2012).","DOI":"10.1016\/j.mce.2012.01.004"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Sallinen P, Saarela S, Ilves M, Vakkuri O, Lepp\u00e4luoto J. The expression of MT<sub>1<\/sub> and MT<sub>2<\/sub> melatonin receptor mRNA in several rat tissues. <i>Life Sci.<\/i>, <b>76<\/b>, 1123\u20131134 (2005).","DOI":"10.1016\/j.lfs.2004.08.016"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Gooneratne NS, Gehrman P, Gurubhagavatula I, Al-Shehabi E, Marie E, Schwab R. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study. <i>J. Clin. Sleep Med.<\/i>, <b>6<\/b>, 572\u2013580 (2010).","DOI":"10.5664\/jcsm.27991"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Kryger M, Wang-Weigand S, Roth T. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. <i>Sleep Breath.<\/i>, <b>11<\/b>, 159\u2013164 (2007).","DOI":"10.1007\/s11325-006-0096-4"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) L\u00e9vy P, Kohler M, McNicholas WT, Barb\u00e9 F, McEvoy RD, Somers VK, Lavie L, P\u00e9pin J-L. Obstructive sleep apnoea syndrome. <i>Nat. Rev. Dis. Prim.<\/i>, <b>1<\/b>, 15015 (2015).","DOI":"10.1038\/nrdp.2015.24"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Liu Y, Gao L, Lv W, Lin L, Wang Y, He H, Jiang F, Feng F. Histological, ultrastructural, and physiological evaluation of a rat model of obstructive sleep apnea syndrome. <i>Med. Sci. Monit.<\/i>, <b>25<\/b>, 1806\u20131813 (2019).","DOI":"10.12659\/MSM.913056"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Patel N, Donahue C, Shenoy A, Patel A, El-Sherif N. Obstructive sleep apnea and arrhythmia: A systemic review. <i>Int. J. Cardiol.<\/i>, <b>228<\/b>, 967\u2013970 (2017).","DOI":"10.1016\/j.ijcard.2016.11.137"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Blatt CM, Rabinowitz SH, Lown B. Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardium. <i>Circ. Res.<\/i>, <b>44<\/b>, 723\u2013730 (1979).","DOI":"10.1161\/01.RES.44.5.723"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Matta R, Verrier R, Lown B. Repetitive extrasystole as an index of vulnerability to ventricular fibrillation. <i>Am. J. Physiol.<\/i>, <b>230<\/b>, 1469\u20131473 (1976).","DOI":"10.1152\/ajplegacy.1976.230.6.1469"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91) Pinto JMB, Kirby DA, Maher TJ, Lown B. Decreases in repetitive extrasystole threshold in the conscious pig with myocardial infarct were reversed by tyrosine. <i>Life Sci.<\/i>, <b>49<\/b>, 419\u2013426 (1991).","DOI":"10.1016\/0024-3205(91)90583-W"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/6\/44_b20-00932\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T05:02:34Z","timestamp":1622869354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/6\/44_b20-00932\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00932","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}